| |
| |
|
| Insider
Information: |
Mullen James C |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
227,563 |
|
|
Indirect Shares
|
75,000 |
|
|
| Direct
Value |
$29,809,992 |
|
|
|
Indirect Value
|
$16,870,500 |
|
|
| Total
Shares |
302,563 |
|
|
| Total
Value |
$46,680,492 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-2.0
|
| Percentage
Gain/Loss : |
 -18.6%
|
-115.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
CEO & President, Direc... |
2010-06-08 |
95,503 |
2010-06-08 |
75,000 |
Premium* |
|
|
Perkinelmer Inc |
PKI |
Director |
2014-11-14 |
45,551 |
2004-04-27 |
0 |
Premium* |
|
|
Patheon NV |
PTHN |
Chief Executive Office... |
2017-08-29 |
0 |
2017-08-29 |
0 |
Premium* |
|
|
Insulet Corp |
PODD |
Director |
2018-05-16 |
7,783 |
2017-08-09 |
0 |
Premium* |
|
|
Editas Medicine, Inc. |
EDIT |
CEO, Director |
2022-01-03 |
75,898 |
2018-05-18 |
0 |
Premium* |
|
|
Thermo Fisher Scientific |
TMO |
Director |
2024-05-22 |
2,828 |
2019-05-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
181 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2009-02-07 |
4 |
D |
$52.48 |
$484,285 |
D/D |
(9,228) |
153,938 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2008-02-07 |
4 |
D |
$61.58 |
$598,866 |
D/D |
(9,725) |
191,650 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2008-02-13 |
4 |
D |
$63.24 |
$616,084 |
D/D |
(9,742) |
181,908 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2010-11-04 |
4 |
OE |
$19.84 |
$198,400 |
D/D |
10,000 |
42,791 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2010-11-04 |
4 |
AS |
$24.00 |
$240,000 |
D/D |
(10,000) |
32,791 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Director |
– • – |
2018-05-18 |
4 |
B |
$38.03 |
$380,252 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2007-02-07 |
4 |
D |
$49.32 |
$549,129 |
D/D |
(11,134) |
46,458 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2006-11-27 |
4 |
OE |
$36.09 |
$451,125 |
D/D |
12,500 |
106,752 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2006-11-27 |
4 |
AS |
$50.99 |
$637,336 |
D/D |
(12,500) |
94,252 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2008-04-15 |
4 |
OE |
$44.59 |
$570,752 |
D/D |
12,800 |
149,300 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2008-04-15 |
4 |
AS |
$64.95 |
$831,360 |
D/D |
(12,800) |
136,500 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2014-02-07 |
4 |
S |
$43.73 |
$566,334 |
D/D |
(12,951) |
43,178 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2014-02-07 |
4 |
OE |
$19.91 |
$288,768 |
D/D |
12,951 |
56,129 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2010-02-25 |
4 |
D |
$54.89 |
$751,883 |
D/D |
(13,698) |
131,149 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
CEO |
• • – |
2021-10-18 |
4 |
S |
$38.03 |
$525,033 |
D/D |
(13,805) |
57,673 |
0 |
% |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2010-02-13 |
4 |
D |
$55.21 |
$907,376 |
D/D |
(16,435) |
95,886 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2009-02-13 |
4 |
D |
$52.42 |
$943,298 |
D/D |
(17,995) |
135,943 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
CEO |
• • – |
2022-01-03 |
4 |
S |
$26.95 |
$491,979 |
D/D |
(18,252) |
75,898 |
0 |
% |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2007-02-06 |
4 |
D |
$48.94 |
$933,531 |
D/D |
(19,075) |
30,925 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
CEO |
• • – |
2021-03-02 |
4 |
B |
$46.27 |
$1,156,800 |
D/D |
25,000 |
35,000 |
2.81 |
% |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2009-02-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,666 |
163,166 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2007-02-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,667 |
57,592 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2008-02-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,667 |
201,375 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2010-06-08 |
4 |
D |
$46.85 |
$1,670,015 |
D/D |
(35,646) |
95,503 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
CEO |
• • – |
2021-12-22 |
4 |
A |
$0.00 |
$0 |
D/D |
36,477 |
94,150 |
0 |
- |
|
181 Records found
|
|
Page 6 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
